Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

Slide Presentation from the AHRQ 2007 Annual Conference

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Summary Plan Description (SPD) Language

Text Description is below the image.
  • Breast Cancer: Normal Risk
    • Screening
      • Mammography and CBE for average risk women aged 40 to 80 once per calendar year. Younger women may qualify for screening if medically indicated.
  • Breast Cancer: High-Risk
    • Counseling on Testing & Preventive Medication and Preventive Treatment
      • Counseling provided as medically indicated and at least once before and once after a BRCA mutation test
    • BRCA Mutation Testing
      • Once per lifetime
    • Preventive Treatment
      • Surgical removal of the breast(s) with or without reconstructive surgery
      • Surgical removal of the ovaries
    • Preventive Medication
      • All FDA-approved breast cancer preventive medications (e.g., tamoxifen) for 5 years—may be extended if medically necessary


Speaker: Kathryn

Previous Slide Previous Slide         Contents         Next Slide Next Slide


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care